REQUEST A DEMO
Total
USD $0.00
Search more companies

Dhyana Med S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dhyana Med S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Dhyana Med S.A.S. is based in Ecuador, with the head office in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on June 11, 2024. 1 (2024) employees currently work for Dhyana Med S.A.S.. There was a net sales revenue increase of 287.15% reported in Dhyana Med S.A.S.’s latest financial highlights for 2025. During that time, Dhyana Med S.A.S.’s total assets grew by 1235.68%. The net profit margin of Dhyana Med S.A.S. decreased by 23.56% in 2025.

Headquarters
Calle Septima, 124
Guayaquil; Guayas;

Contact Details: Purchase the Dhyana Med S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Dhyana Med S.A.S. report to view the information.
Registered Capital:
Purchase the Dhyana Med S.A.S. report to view the information.
Financial Auditors:
Purchase the Dhyana Med S.A.S. report to view the information.
Incorporation Date:
June 11, 2024
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Dhyana Med S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
287.15%
Total Operating Revenue
287.15%
Operating Profit
134.65%
EBITDA
233.54%
Net Profit/Loss for the Period
176.06%
Total Assets
1235.68%
Total Equity
168.8%
Operating Profit Margin
-38.05%
Net Profit Margin
-23.56%
Return on Equity (ROE)
2.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?